HHS Awards $20M for Influenza-Like Illness Detection Program to Evidation Health
Contract Overview
Contract Amount: $20,000,000 ($20.0M)
Contractor: Evidation Health, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2023-09-28
End Date: 2024-11-25
Contract Duration: 424 days
Daily Burn Rate: $47.2K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: R&D
Official Description: INFLUENZA LIKE ILLNESS (ILI) DETECTION PROGRAM
Place of Performance
Location: SAN MATEO, SAN MATEO County, CALIFORNIA, 94401
Plain-Language Summary
Department of Health and Human Services obligated $20.0 million to EVIDATION HEALTH, INC. for work described as: INFLUENZA LIKE ILLNESS (ILI) DETECTION PROGRAM Key points: 1. The contract focuses on R&D in Biotechnology, a critical area for public health. 2. Evidation Health, Inc. secured this definitive contract. 3. The award is for a Firm Fixed Price contract, indicating clear cost expectations. 4. This program aims to improve ILI detection capabilities.
Value Assessment
Rating: good
The $20 million award for the ILI Detection Program appears reasonable given the scope of research and development in biotechnology. Benchmarking against similar R&D contracts in public health would provide further context.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a robust price discovery process. This method typically leads to more competitive pricing.
Taxpayer Impact: The use of full and open competition aims to ensure taxpayer funds are used efficiently for critical public health research.
Public Impact
Enhances national preparedness for influenza outbreaks. Supports advancements in disease surveillance technology. Potential for improved public health response strategies. Contributes to the broader field of biotechnology research.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Positive Signals
- Full and open competition utilized.
- Firm Fixed Price contract type.
- Focus on critical public health R&D.
Sector Analysis
This contract falls under Research and Development in Biotechnology, a sector vital for advancing medical science and public health initiatives. Spending in this area is often driven by specific program needs and innovation goals.
Small Business Impact
The data indicates this contract was not awarded to a small business. Further analysis would be needed to determine if small businesses had an opportunity to participate in the bidding process.
Oversight & Accountability
The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response, is overseeing this contract. Standard oversight mechanisms for R&D contracts should be in place.
Related Government Programs
- Research and Development in Biotechnology (except Nanobiotechnology)
- Department of Health and Human Services Contracting
- Office of Assistant Secretary for Preparedness and Response Programs
Risk Flags
- Potential for R&D project delays or failures.
- Scalability and cost-effectiveness of developed solutions.
- Integration challenges with existing public health infrastructure.
Tags
research-and-development-in-biotechnolog, department-of-health-and-human-services, ca, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $20.0 million to EVIDATION HEALTH, INC.. INFLUENZA LIKE ILLNESS (ILI) DETECTION PROGRAM
Who is the contractor on this award?
The obligated recipient is EVIDATION HEALTH, INC..
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).
What is the total obligated amount?
The obligated amount is $20.0 million.
What is the period of performance?
Start: 2023-09-28. End: 2024-11-25.
What specific technological advancements are expected from this ILI detection program?
The program is expected to yield advancements in real-time influenza-like illness detection, potentially through novel data analytics, wearable sensor integration, or improved diagnostic methodologies. The goal is to enhance the speed and accuracy of identifying and tracking outbreaks, thereby informing public health interventions more effectively.
What are the primary risks associated with the R&D nature of this contract?
The primary risks stem from the inherent uncertainty in research and development. This includes the possibility of technical challenges, failure to achieve desired outcomes within the project timeline, or the development of solutions that may not be scalable or cost-effective for widespread implementation. Market adoption and integration with existing health systems also pose risks.
How will the effectiveness of the ILI detection program be measured?
Effectiveness will likely be measured by key performance indicators such as the accuracy and timeliness of ILI detection compared to traditional methods, the program's ability to identify emerging strains or patterns, and its contribution to improved public health response decisions. User adoption rates and feedback from public health agencies will also be crucial metrics.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology (except Nanobiotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 101 S ELLSWORTH AVE STE 210, SAN MATEO, CA, 94401
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $20,000,000
Exercised Options: $20,000,000
Current Obligation: $20,000,000
Actual Outlays: $16,527,164
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2023-09-28
Current End Date: 2024-11-25
Potential End Date: 2025-04-06 00:00:00
Last Modified: 2025-05-08
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →